Almost 40% of the county’s 2024 homicides were from instances of IPV.
Spotlight on VPM Original Content
Virginia News
NPR News
Virginia News
-
The funding is still contingent on General Assembly approval.
-
The phrase, reportedly coined in Richmond to persuade Virginia colonists to prepare for war, has been used by protesters across the world.
-
The $11.4B federal ‘claw back’ has led to layoffs and public health cuts nationwide.
-
The spending plan includes a $426M water treatment plant that could be online by 2033.
-
The governor removed a barrier to local betting parlors despite bipartisan support.
-
The governor axed another Democrat-led effort to create a legal retail market.
NPR News
-
Stocks rallied after the U.S. and China said they would slash tariffs on each other's imports for 90 days.
-
Pope Leo XIV once attended Villanova University. Catholics packed the St. Thomas of Villanova church to celebrate Sunday Mass and the new pope.
-
Edan Alexander, an Israeli soldier raised in New Jersey, is believed to be the last living U.S. citizen captured by Hamas on Oct. 7, 2023. Four other Americans' bodies are still held in Gaza.
-
The remarks come just one day after the pope called for a ceasefire and access to humanitarian aid in Gaza and an end to the war in Ukraine.
-
Government incentives for climate-friendly upgrades are confusing to navigate, and it can be hard to find businesses that sell them. So a new industry is emerging to help: the decarbonization coach.
Arts & Culture
- Tara Roberts helps scuba divers uncover slave shipwrecks
- New Burying Ground honors enslaved labor at University of Richmond
- Museums, libraries and cultural groups grapple with federal humanities cuts
- ‘Idleness and boredom’: Virginia juvenile justice system strained by staffing shortages
Listen to VPM
- VPM Daily Newscast: Richmond City Council finalizes $3 billion FY26 budget
- Guest conductor Michael Repper leads the Richmond Symphony in Berlioz's Symphonie Fantastique
- VPM Daily Newscast: ‘Catalyst’ UVA Manning Institute for Biotechnology
- Interview: Keep finds the new normal